Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cejinzan
- Development stage
- Phase 2
- Lead developer
- Shandong Institute of Pharmaceutical Industry
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Cejinzan is a traditional Chinese medicine (TCM) formulation developed as a topical patch for the treatment of recurrent aphthous ulcers (RAU). Developed by the Shandong Institute of Biological Medicine, it is specifically investigated for mild RAU using TCM syndrome stratification to guide therapy. The patch is designed to be applied directly to the oral mucosa, where it likely exerts anti-inflammatory and mucosal-protective effects to accelerate ulcer healing and provide symptomatic relief. As a botanical-based therapy, its mechanism involves a complex interplay of multiple active constituents typical of herbal preparations.
- Brand names
- Cejinzan
- Other names
- Cejinzan oral ulcer patch
Beyond the preview
Go deeper on Cejinzan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cejinzan.